CSF1R and neoplasm: Acquired resistance to long-term CSF-1R inhibition was correlated with increased insulin-like growth factor (IGF-1) signaling between macrophages and tumor cells, leading to aberrant activation of phosphatidylinositol 3-kinase (PI3K) signaling, therefore promoting tumor cell survival and invasion (77).